title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Treating Geographic Atrophy Remains a Tough Call for Ophthalmologists as They Voice Hesitancy to Prescribe Complement Inhibitors,20240627T124955,https://www.benzinga.com/pressreleases/24/06/g39524015/treating-geographic-atrophy-remains-a-tough-call-for-ophthalmologists-as-they-voice-hesitancy-to-p,BLTE,0.045396,Somewhat-Bullish,0.21708
"Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday",20220705T083503,https://www.benzinga.com/news/22/07/27948361/accolade-shares-jump-around-29-heres-75-biggest-movers-from-friday,BLTE,0.061758,Neutral,0.020428
70 Biggest Movers From Friday,20220502T094646,https://www.benzinga.com/news/22/05/26923653/70-biggest-movers-from-friday,BLTE,0.078844,Neutral,0.003429
